Marshall Wace LLP Sells 242,562 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Marshall Wace LLP decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 56.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 190,169 shares of the medical equipment provider's stock after selling 242,562 shares during the quarter. Marshall Wace LLP owned approximately 0.05% of Intuitive Surgical worth $99,261,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of ISRG. Atala Financial Inc acquired a new position in shares of Intuitive Surgical in the fourth quarter worth approximately $25,000. Hurley Capital LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at $28,000. Berbice Capital Management LLC bought a new position in Intuitive Surgical during the fourth quarter worth $26,000. BankPlus Trust Department acquired a new position in Intuitive Surgical in the fourth quarter valued at $28,000. Finally, Summit Securities Group LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Barclays upped their target price on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the stock a "buy" rating in a research note on Monday, April 14th. Royal Bank of Canada lifted their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. UBS Group increased their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research report on Monday, January 27th. Finally, Wells Fargo & Company boosted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $611.81.

Intuitive Surgical Trading Up 0.3 %

Shares of NASDAQ ISRG traded up $1.40 during mid-day trading on Friday, hitting $482.74. The company had a trading volume of 1,618,989 shares, compared to its average volume of 1,589,481. The stock's 50-day moving average price is $522.23 and its 200-day moving average price is $532.34. The company has a market capitalization of $171.94 billion, a price-to-earnings ratio of 75.31, a P/E/G ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 1 year low of $364.31 and a 1 year high of $616.00.

Insider Buying and Selling at Intuitive Surgical

In related news, CFO Jamie Samath sold 269 shares of the business's stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the transaction, the chief financial officer now owns 3,282 shares of the company's stock, valued at approximately $1,936,380. The trade was a 7.58 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Fredrik Widman sold 810 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the sale, the vice president now owns 473 shares in the company, valued at $271,397.94. This represents a 63.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 in the last quarter. 0.70% of the stock is currently owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.